Industry: Pharmaceuticals, Biotechnology
AVEO is a private biopharmaceutical company focused on the discovery and development of novel cancer therapeutics. The Company utilizes its proprietary, genetically-defined cancer models for the identification and validation of novel cancer targets, and has begun to build an impressive portfolio of drug discovery and development programs around these high-value targets. AVEO’s most advanced clinical program, AV-412, is currently in Phase I clinical trials. AVEO also leverages its Human Response PredictionÔ Platform to allow for the identification of genetic profiles that correspond with patient responsiveness. AVEO is located in Cambridge, Massachusetts. ( www.aveopharma.com )
AVEO Pharmaceuticals , Inc.
75 Sidney Street, 4Th Floor
Cambridge, Massachusetts 02139
USA
Tel: (617) 299-5000
Fax: (617) 995-4995